Praxis Precision Medicines, Inc. beat EPS estimates 50% of the time across 16 reported quarters (8 beats, 8 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-3.88 | — | — | Miss |
| Q12026 FY2026 | $-3.58 | $-3.20 | +10.6% | Beat |
| 2026-04-30 | — | — | — | Miss |
| 2026-02-27 | $-3.00 | — | — | Miss |
| 2026-02-19 | $-3.00 | — | — | Miss |
| Q3 FY2025 | $-3.45 | $-3.36 | +2.6% | Beat |
| Q3 FY2025 | $-3.40 | $-3.31 | +2.6% | Beat |
| Q3 FY2025 | $-3.20 | $-3.29 | -2.8% | Miss |
| 2025-02-28 | $-2.76 | $-2.94 | -6.5% | Miss |
| Q3 FY2024 | $-2.01 | $-2.75 | -36.8% | Miss |
| Q3 FY2024 | $-2.38 | $-1.74 | +26.9% | Beat |
| Q3 FY2024 | $-2.01 | $-2.84 | -41.3% | Miss |
Back to PRAX overview · PRAX holders · PRAX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.